Fresenius agrees USD4.75bn deal for Akorn

25 April 2017 - Deborah Wilkes


German healthcare company Fresenius has agreed to acquire US generics, OTC and animal health company Akorn in a deal worth approximately USD4.75 billion, including debt.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: